Literature DB >> 15657753

[Significance of dendritic cells for the immunotherapy of tumors].

J B Weise1, S Maune, D Kabelitz, A Heiser.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15657753     DOI： 10.1007/s00106-004-1201-2

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  38 in total

Review 1.  The role of chemokines in the regulation of dendritic cell trafficking.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Leukoc Biol       Date:  1999-07       Impact factor: 4.962

Review 2.  Exploiting dendritic cells to improve vaccine efficacy.

Authors:  Ralph M Steinman; Melissa Pope
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 3.  Dendritic cell immunotherapy: mapping the way.

Authors:  Carl G Figdor; I Jolanda M de Vries; W Joost Lesterhuis; Cornelis J M Melief
Journal:  Nat Med       Date:  2004-05       Impact factor: 53.440

4.  Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine.

Authors:  Michael G E O'Rourke; Maree Johnson; Catherine Lanagan; Janet See; Jie Yang; John R Bell; Greg J Slater; Beverley M Kerr; Beth Crowe; David M Purdie; Suzanne L Elliott; Kay A O Ellem; Christopher W Schmidt
Journal:  Cancer Immunol Immunother       Date:  2003-04-08       Impact factor: 6.968

5.  Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.

Authors:  A Heiser; M A Maurice; D R Yancey; D M Coleman; P Dahm; J Vieweg
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

6.  Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro.

Authors:  A Heiser; P Dahm; D R Yancey; M A Maurice; D Boczkowski; S K Nair; E Gilboa; J Vieweg
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

7.  Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

Authors:  S K Nair; A Heiser; D Boczkowski; A Majumdar; M Naoe; J S Lebkowski; J Vieweg; E Gilboa
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

8.  A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma.

Authors:  Barbara J Gitlitz; Arie S Belldegrun; Amnon Zisman; Debby H Chao; Allan J Pantuck; Andreas Hinkel; Peter Mulders; Nancy Moldawer; Cho-Lea Tso; Robert A Figlin
Journal:  J Immunother       Date:  2003 Sep-Oct       Impact factor: 4.456

9.  Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen.

Authors:  Mark Smithers; Kathleen O'Connell; Susan MacFadyen; Melita Chambers; Kathryn Greenwood; Amanda Boyce; Ibtissam Abdul-Jabbar; Kylie Barker; Karen Grimmett; Euan Walpole; Ranjeny Thomas
Journal:  Cancer Immunol Immunother       Date:  2002-11-13       Impact factor: 6.968

10.  Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.

Authors:  B Sauter; M L Albert; L Francisco; M Larsson; S Somersan; N Bhardwaj
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.